Xolair Lawsuits – Cardiovascular Injuries July 16, 2024 …product of Genentech, Inc., a U.S. subsidiary of Swiss-based pharmaceutical company F. Hoffman-LaRoche AG (Roche). The prescription drug is marketed and sold by Genentech in the U.S. in cooperation with… Read More
Potentially Dangerous Arthritis Drug Wins FDA Approval for Cancer Treatment Side Effect June 19, 2024 …for “Chimeric Antigen Receptor T-Cell.” CAR-T therapy is a new, sophisticated treatment for leukemia that shows great promise – but there is a serious, possibly fatal side effect, which Roche and Genentech… Read More